Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
other: SNIF
Title:
Unnamed
Year:
2021

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
other: migration from SNIF
Justification for non-LLNA method:
migration from SNIF

Test material

1
Chemical structure
Reference substance name:
Potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
EC Number:
414-100-0
EC Name:
Potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
Cas Number:
154336-20-6
Molecular formula:
C56H42Cl2K4N16Na4O32S10
IUPAC Name:
potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Details on test animals and environmental conditions:
Number of animals in test group: 20
Number of animals in negative control group: 10

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
epicutaneous, semiocclusive
Vehicle:
petrolatum
Concentration / amount:
25 %
Route:
intradermal
Vehicle:
water
Concentration / amount:
1 %
Challengeopen allclose all
Route:
epicutaneous, semiocclusive
Vehicle:
petrolatum
Concentration / amount:
25 %
Route:
intradermal
Vehicle:
water
Concentration / amount:
1 %
No. of animals per dose:
test group: 20; negative control group: 10

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
10
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
10
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
20
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
25 %
No. with + reactions:
3
Total no. in group:
20

Any other information on results incl. tables

Signs of irritation during induction: None.
Evidence of sensitisation of each challenge concentration: 3 at 25 %.
Other observations:
One animal in the test group died prior to application. Bladder stone and intestinal intussusception were observed in this animal. It was assumed that the death was not due to administration of the test material.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
not classified